BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 38286983)

  • 1. RUNX1/NPM1/H3K4me3 complex contributes to extracellular matrix remodeling via enhancing FOSL2 transcriptional activation in glioblastoma.
    Cui X; Huo D; Wang Q; Wang Y; Liu X; Zhao K; You Y; Zhang J; Kang C
    Cell Death Dis; 2024 Jan; 15(1):98. PubMed ID: 38286983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RUNX1 contributes to the mesenchymal subtype of glioblastoma in a TGFβ pathway-dependent manner.
    Zhao K; Cui X; Wang Q; Fang C; Tan Y; Wang Y; Yi K; Yang C; You H; Shang R; Wang J; Kang C
    Cell Death Dis; 2019 Nov; 10(12):877. PubMed ID: 31754093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Augmented expression of RUNX1 deregulates the global gene expression of U87 glioblastoma multiforme cells and inhibits tumor growth in mice.
    Bogoch Y; Friedlander-Malik G; Lupu L; Bondar E; Zohar N; Langier S; Ram Z; Nachmany I; Klausner JM; Pencovich N
    Tumour Biol; 2017 Apr; 39(4):1010428317698357. PubMed ID: 28443460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RUNX1 (RUNX family transcription factor 1), a target of microRNA miR-128-3p, promotes temozolomide resistance in glioblastoma multiform by upregulating multidrug resistance-associated protein 1 (MRP1).
    Xu J; Song J; Xiao M; Wang C; Zhang Q; Yuan X; Tian S
    Bioengineered; 2021 Dec; 12(2):11768-11781. PubMed ID: 34895074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CEBPD is a master transcriptional factor for hypoxia regulated proteins in glioblastoma and augments hypoxia induced invasion through extracellular matrix-integrin mediated EGFR/PI3K pathway.
    Mao XG; Xue XY; Lv R; Ji A; Shi TY; Chen XY; Jiang XF; Zhang X
    Cell Death Dis; 2023 Apr; 14(4):269. PubMed ID: 37059730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. USP10 deubiquitinates RUNX1 and promotes proneural-to-mesenchymal transition in glioblastoma.
    Qiu W; Xiao Z; Yang Y; Jiang L; Song S; Qi X; Chen Y; Yang H; Liu J; Chu L
    Cell Death Dis; 2023 Mar; 14(3):207. PubMed ID: 36949071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Force-mediated proinvasive matrix remodeling driven by tumor-associated mesenchymal stem-like cells in glioblastoma.
    Lim EJ; Suh Y; Kim S; Kang SG; Lee SJ
    BMB Rep; 2018 Apr; 51(4):182-187. PubMed ID: 29301607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glioblastoma-educated mesenchymal stem-like cells promote glioblastoma infiltration via extracellular matrix remodelling in the tumour microenvironment.
    Kim SM; Lim EJ; Yoo KC; Zhao Y; Kang JH; Lim EJ; Shin I; Kang SG; Lim HW; Lee SJ
    Clin Transl Med; 2022 Aug; 12(8):e997. PubMed ID: 35908277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of RUNX1 blocks the differentiation of lung fibroblasts to myofibroblasts.
    Dubey S; Dubey PK; Umeshappa CS; Ghebre YT; Krishnamurthy P
    J Cell Physiol; 2022 Apr; 237(4):2169-2182. PubMed ID: 35048404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mode and dynamics of glioblastoma cell invasion into a decellularized tissue-derived extracellular matrix-based three-dimensional tumor model.
    Koh I; Cha J; Park J; Choi J; Kang SG; Kim P
    Sci Rep; 2018 Mar; 8(1):4608. PubMed ID: 29545552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microenvironmental Modulation of Decorin and Lumican in Temozolomide-Resistant Glioblastoma and Neuroblastoma Cancer Stem-Like Cells.
    Farace C; Oliver JA; Melguizo C; Alvarez P; Bandiera P; Rama AR; Malaguarnera G; Ortiz R; Madeddu R; Prados J
    PLoS One; 2015; 10(7):e0134111. PubMed ID: 26230845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HSP47 Promotes Glioblastoma Stemlike Cell Survival by Modulating Tumor Microenvironment Extracellular Matrix through TGF-β Pathway.
    Jiang X; Zhou T; Wang Z; Qi B; Xia H
    ACS Chem Neurosci; 2017 Jan; 8(1):128-134. PubMed ID: 27696866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decellularized brain extracellular matrix slice glioblastoma culture model recapitulates the interaction between cells and the extracellular matrix without a nutrient-oxygen gradient interference.
    Wang C; Zhao Q; Zheng X; Li S; Chen J; Zhao H; Chen F; Cui L; Li W
    Acta Biomater; 2023 Mar; 158():132-150. PubMed ID: 36565784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Runt-related transcription factor 1 promotes apoptosis and inhibits neuroblastoma progression in vitro and in vivo.
    Hong M; He J; Li D; Chu Y; Pu J; Tong Q; Joshi HC; Tang S; Li S
    J Exp Clin Cancer Res; 2020 Mar; 39(1):52. PubMed ID: 32197643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The tumor microenvironment strongly impacts master transcriptional regulators and gene expression class of glioblastoma.
    Cooper LA; Gutman DA; Chisolm C; Appin C; Kong J; Rong Y; Kurc T; Van Meir EG; Saltz JH; Moreno CS; Brat DJ
    Am J Pathol; 2012 May; 180(5):2108-19. PubMed ID: 22440258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RUNX1 inhibits proliferation and induces apoptosis of t(8;21) leukemia cells
    Liu S; Xing Y; Lu W; Li S; Tian Z; Xing H; Tang K; Xu Y; Rao Q; Wang M; Wang J
    Haematologica; 2019 Aug; 104(8):1597-1607. PubMed ID: 30792202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RUNX1 and cancer.
    Lin TC
    Biochim Biophys Acta Rev Cancer; 2022 May; 1877(3):188715. PubMed ID: 35271994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of RUNX1-Activated Osteopontin Facilitates Burn Wound Healing by Activating the MAPK Pathways.
    Ji W; Sun Z; Yang Y; Hu M; Zhang Q; Fu J; Chen J; Huang Y; Cheng Y
    J Burn Care Res; 2023 Nov; 44(6):1371-1381. PubMed ID: 36913234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-195 connects lncRNA RUNX1-IT1 and cyclin D1 to regulate the proliferation of glioblastoma cells.
    Wu Z
    Int J Neurosci; 2023 Jan; 133(1):13-18. PubMed ID: 33507136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of RUNX1 transcription factor activity by a CBFA2T3-mimicking peptide: application to B cell precursor acute lymphoblastic leukemia.
    Jakobczyk H; Debaize L; Soubise B; Avner S; Rouger-Gaudichon J; Commet S; Jiang Y; Sérandour AA; Rio AG; Carroll JS; Wichmann C; Lie-A-Ling M; Lacaud G; Corcos L; Salbert G; Galibert MD; Gandemer V; Troadec MB
    J Hematol Oncol; 2021 Mar; 14(1):47. PubMed ID: 33743795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.